“The [pharmacy] industry argues that patients are inconvenienced and their choices are restricted by what appears to be tiering of pharmacy providers. This has been a common practice with health plans offering HMOs and PPOs in Medicare for many years. It would seem to have little impact on the satisfaction of Part D beneficiaries."
— Wayne Miller, a senior consultant at Gorman Health Group, LLC, told AIS’s Drug Benefit News.
No comments:
Post a Comment